Clearstead Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22.3K	Sell	1,000 -17	-2%	-$406	﹤0.01%	1434
2025 Q4	$27.2K	Sell	1,017 -257	-20%	-$6.14K	﹤0.01%	1618
2025 Q3	$27.2K	Buy	1,274 +271	+27%	+$6.41K	﹤0.01%	1504
2025 Q2	$21.6K	Buy	1,003 +3	+0.3%	+$56	﹤0.01%	1588
2025 Q1	$16.6K	Hold	1,000	–	–	﹤0.01%	1473
2024 Q4	$18.4K	Hold	1,000	–	–	﹤0.01%	1415
2024 Q3	$15.4K	Hold	1,000	–	–	﹤0.01%	1494
2024 Q2	$16.3K	Hold	1,000	–	–	﹤0.01%	1436
2024 Q1	$15.2K	Hold	1,000	–	–	﹤0.01%	989
2023 Q4	$31.3K	Sell	1,000 -1,000	-50%	-$23.9K	﹤0.01%	857
2023 Q3	$41.7K	Buy	2,000 +1,000	+100%	+$27.2K	﹤0.01%	912
2023 Q2	$23.9K	Hold	1,000	–	–	﹤0.01%	871
2023 Q1	$18.8K	Hold	1,000	–	–	﹤0.01%	862
2022 Q4	$15.9K	Hold	1,000	–	–	﹤0.01%	836
2022 Q3	$16K	Hold	1,000	–	–	﹤0.01%	805
2022 Q2	$14K	Hold	1,000	–	–	﹤0.01%	864
2022 Q1	$24K	Hold	1,000	–	–	﹤0.01%	820
2021 Q4	$23K	Sell	1,000 -508	-34%	-$10.2K	﹤0.01%	790
2021 Q3	$25K	Hold	1,508	–	–	﹤0.01%	739
2021 Q2	$37K	Hold	1,508	–	–	﹤0.01%	601
2021 Q1	$39K	Hold	1,508	–	–	﹤0.01%	579
2020 Q4	$81K	Hold	1,508	–	–	0.01%	448
2020 Q3	$62K	Buy	1,508 +1,008	+202%	+$43.5K	0.01%	435
2020 Q2	$24K	Hold	500	–	–	﹤0.01%	509
2020 Q1	$21K	Buy	+500	New	+$20.6K	﹤0.01%	498